Skip to content
10-K

Annual Report

Pharma-Bio Serv, Inc. PBSV

0001654954-25-000915

← back to feed
Filed
Jan 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Dividends Paid FY 2024 · Dec 15, 2023 $1.72M
Dividends Paid FY 2024 · Oct 31, 2023 $1.72M
Shares Diluted FY 2024 · Oct 31, 2023 23M sh
Stock Repurchased FY 2024 · Oct 31, 2023 $34.34K
Capex FY 2024 · Oct 31, 2023 $7.25K
Operating Cash Flow FY 2024 · Oct 31, 2023 $1.89M
Current Liabilities FY 2024 · Oct 31, 2023 $2.15M
Total Liabilities FY 2024 · Oct 31, 2023 $3.78M
Current Assets FY 2024 · Oct 31, 2023 $19.4M
Total Assets FY 2024 · Oct 31, 2023 $19.9M
Eps Diluted FY 2024 · Oct 31, 2023 $0.06
Sga Expense FY 2024 · Oct 31, 2023 $3.95M
Net Income FY 2024 · Oct 31, 2023 $1.31M
Operating Income FY 2024 · Oct 31, 2023 $1.12M
Gross Profit FY 2024 · Oct 31, 2023 $5.07M
Cost Of Revenue FY 2024 · Oct 31, 2023 $11.91M
Revenue FY 2024 · Oct 31, 2023 $16.98M
Stockholders Equity FY 2024 · Oct 31, 2022 $16.56M